Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tubbs

Showing results (351-360 of 413) with videos related to

Pageof 42
Sort By:
Breast (Edinburgh, Scotland)|May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institutionJoseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
The American Journal of Surgical Pathology|February 4, 2012
Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 casesShannon Bieliauskas, Raymond R Tubbs, Chris M Bacon, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1994
Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastasesB P Barna, M J Thomassen, M Maier, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancyT Olencki, J Finke, R Tubbs, et al.
The Journal of Molecular Diagnostics : JMD|March 19, 2013
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISHEugen C Minca, Bryce P Portier, Zhen Wang, et al.
Cytometry|December 31, 1997
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinationsC C Stewart, F G Behm, J L Carey, et al.
American Journal of Clinical Pathology|January 11, 2007
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findingsBrian J Yoder, Marek Skacel, Ryan Hedgepeth, et al.
Cancer Research|December 15, 1989
Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinomaT Hashimura, R R Tubbs, R Connelly, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistryBryce P Portier, Zhen Wang, Erinn Downs-Kelly, et al.
Pageof 42

Showing results (351-360 of 413) with videos related to

Sort By:
Pageof 42
Breast (Edinburgh, Scotland)|May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institutionJoseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
The American Journal of Surgical Pathology|February 4, 2012
Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 casesShannon Bieliauskas, Raymond R Tubbs, Chris M Bacon, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1994
Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastasesB P Barna, M J Thomassen, M Maier, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancyT Olencki, J Finke, R Tubbs, et al.
The Journal of Molecular Diagnostics : JMD|March 19, 2013
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISHEugen C Minca, Bryce P Portier, Zhen Wang, et al.
Cytometry|December 31, 1997
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinationsC C Stewart, F G Behm, J L Carey, et al.
American Journal of Clinical Pathology|January 11, 2007
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findingsBrian J Yoder, Marek Skacel, Ryan Hedgepeth, et al.
Cancer Research|December 15, 1989
Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinomaT Hashimura, R R Tubbs, R Connelly, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistryBryce P Portier, Zhen Wang, Erinn Downs-Kelly, et al.
Pageof 42